A Phase I/II Study of Cisplatin and Radiation in Combination With Sorafenib in Cervical Cancer

NCT00510250 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Cancer of the Cervix

Interventions

DRUG: Sorafenib
DRUG: Cisplatin
PROCEDURE: Radiation

Sponsor

University Health Network, Toronto

Collaborators

[object Object]